The Institute for Healthcare Improvement (IHI), an independent not-for-profit organization based in Boston, Massachusetts, is a leading innovator, convener, partner, and driver of results in health and health care improvement worldwide. At our core, we believe everyone should get the best care and health possible. This passionate belief fuels our mission to improve health and health care.
Episodes
Thursday Aug 09, 2018
Author in the Room: Postlicensure Safety Surveillance for HPV Vaccine
Thursday Aug 09, 2018
Thursday Aug 09, 2018
October 2009 Author in the Room® Teleconference
Author: John Iskander MD MPH
Summary Points:
- Since quadrivalent HPV vaccine was licensed in June 2006, more than 23 million doses have been administered nationally.
- There were a total of 12,424 reports to the Vaccine Adverse Event Reporting System (VAERS) of adverse events following HPV vaccination through December 2008. The vast majority (94 percent) of adverse events reported to VAERS after receiving this vaccine have not been considered serious. The findings of this first published post-licensure safety review were generally not different from what is seen in safety reviews of other vaccines recommended for 9- to 26-year-olds.
- The most common events reported were syncope, local reactions at the site of immunization (pain and redness), dizziness, nausea, and headache.
Version: 20241125
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.